Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376
Clinical trial NCT04961632 · UNKNOWN
Trial details
- NCT number
- NCT04961632
- Sponsor
- National Cancer Centre, Singapore
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-23
- Primary completion
- 2025-11-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.